Gastrointestinal stimulation device
- Publication number
- CA2543209A1 CA2543209A1 CA 2543209 CA2543209A CA2543209A1 CA 2543209 A1 CA2543209 A1 CA 2543209A1 CA 2543209 CA2543209 CA 2543209 CA 2543209 A CA2543209 A CA 2543209A CA 2543209 A1 CA2543209 A1 CA 2543209A1
- Grant status
- Patent type
- Prior art keywords
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
- A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
- A61N1/36007—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation of urogenital or gastrointestinal organs, e.g. for incontinence control
GASTROINTESTINAL STIMULATION DEVICE
Field of the Invention:
The invention relates to a stimulation device and method for stimulating a portion of the gastrointestinal tract and in one particular embodiment to a device and method for stimulating the duodenum to control the pylorus and/or to treat obesity.
Background of the Invention:
In general when food is ingested into the stomach, initially, the elastic upper portion or fundus accommodates the food and the fundus expands. As food enters and the fundus expands there is a pressure gradient created in the stomach between the fundus and the antrum (fundus pylori). A
number of things occur at this time. Fluids tend to be pushed through the pylorus, which acts as a leaky valve. Peristaltic contractions move down the stomach from the fundus into the antrum to mix,and break down food and propel small particles through the pylorus into the duodenum. In healthy human stomachs, peristalsis is believed to be controlled at least in part by a region of the stomach identified near the interface of the fundus and the corpus along the greater curvature. In this region, there are cells believed to govern the organs' periodic contractile behavior that generate and propagate rhythmic electrical signals that correspond to the contractile behavior of the stomach. These characteristic contractions are believed to create, a pressure gradient between the fundus pylori (or antrum) and duodenum that relates to the rate of gastric emptying. When the contractions begin, the pylorus is generally closed, although fluid and small particles leak through the valve. As contractions or electrical activity corresponding to the contractions reach pylorus, the pylorus begins to open or relax. Thus, as the stomach churns and breaks down food in a healthy stomach, the pylorus begins to open. As this is occurring, there may be electrical activity in the duodenum as well. Retrograde electrical activity from the duodenum, i.e. contractions or electrical activity in the direction of the pylorus tends to cause the pylorus to close, thus preventing bile and pancreatic juices from backing up into the stomach. Accordingly, the opening and closing of the pylorus is influenced by electrical stimulation input from both of its ends.
In a number of disease states or conditions, the contractions of the stomach and/or the opening and closing of the pylorus is irregular. Gastroparesis may result from insufficient contractions to churn food, move food through the pylorus, and/or open the pylorus, among other things, resulting in gastro-retention of food. In another motility disorder known as dumping syndrome, the stomach empties at an abnormally high rate into the small intestine causing various gastrointestinal disorders. It has also been observed that in obese patients, gastric emptying tends to be at a higher than normal rate. It is believed that obesity may be treated by altering gastric motility to cause the stomach to slow gastric emptying.
Accordingly, it would be desirable to provide a device and method for controlling gastric emptying. Further, it would be desirable to provide a device and method that controls the contracting and relaxation of the pylorus according to a desired increase or decrease in gastric emptying.
Some devices have been proposed to constrict the stomach to reduce stomach volume. These devices are typically implanted in a relatively invasive procedure and operate to constrict the stomach but do not enable periodic control of the stomach emptying. Some devices have been proposed to interfere with the peristaltic motion of the gastrointestinal tract and especially the stomach, to slow the movement of food from the stomach. These devices control the contractions of the stomach but are not directed to opening and closing the pylorus outside of the context of control ling peristalsis of the stomach. Furthermore, most of these devices require open or laparoscopic surgery in which a stimulator unit is implanted subcutaneously adjacent the abdomen wall with leads extending to the stomach where electrodes are attached.
Artificial sphincters, for opening and closing sphincters including the pylorus have been proposed. These devices typically involve placing a constricting member around the sphincters in a relatively invasive prose dure.
Accordingly it would be desirable to provide a relatively easily implanted device and method for controlling the opening and/or closing of the pylorus. It would further be desirable to provide a method and device for treating obesity.
Summary of the Invention:
The invention provides a fixation device for holding stimulating electrodes in electrical cont act with the wall of a portion of the gastrointestinal tract. In one embodiment, the fixation device includes an expandabl a member that fixes the electrodes in electrical contact with the gastrointestinal tract wall. According to one embodiment, the fixation device comprises a relatively tubular shaped structure that holds stimulating electrodes adjacent the wall of the duodenum while permitting the passage of materials through the device.
According to another embodiment of the invention, the fixation device comprises a self-expanding tubular member.
The present invention further provide s an implantable device and method for controlling the opening and/or closing of the pylorus. In particular, one embodiment comprises a device and method for stimulating the duodenum to control the closing/and or opening of the pylorus. According to this embodiment, electrodes are coupled to the wall of the duodenum. In one embodiment, the electrodes are coupled to the duodenum above the duct through which bile and pancreatic secretions empty into the small intestine. Electrical stimulation pulses are delivered by an electronic circuit through the electrodes. The stimulation pulses that travel in a deep retrograde direction end to cause the pylorus to contract and close. The stimulation may be delivered after sensing a meal or that food has been ingested. For example, detecting a change in temperature due to food particles not at body temperature. Or, the stimulat ion may be user activated whereby the user turns on the device after ingesting a meal.
The stimulation in one embodiment is set to continue for a predetermined period of time. Thus, where a patient's typical rate of gastric emptying is greater that desired, such emptying may be slowed using the stimulator.
The present invention also provides a method for treating obesity by controlling the pylorus to retain food in the stomach for a desired period of time, among other things to provide a feeling of satiety and/or to reduce hunger.
According to one embodiment, the pylorus's contraction is controlled by electrical stimulation of the duodenum. The retrograde propagation of the stimulation acts to close or cause contraction of the pylorus.
Brief Description of the Drawings:
Figure 1 is a side cutaway view of a stomach and duodenum with. an implanted stimulator according to an embodiment of the invention.
Figure 1A is a side view of the fixation device of the stimulator of Figure 1 in a compressed configuration.
Figure 1B is a cross sectional view of Figure 1A along the lines 1B-lB.
Figure 1C is a side view of the fixation device of the stimulator of Figure 1 in an expanded configuration Figure 1D is a cross-sectional view of Figure 1C along the lines 1D-1D.
Figure 1E is a top view of a portion of the stimulator illustrated in Figure 1A.
Figure 1F is a schematic side view of the electrode housing of the stimulator of Figures 1, and lA-1E.
Figure 2 is an alternative electrode housing for the l0 stimulator of Figure 1 in which electronics are encased in the electrode housing.
Figure 3 illustrates another embodiments of an implanted stimulator according to the invention.
Figure illustrates another embodiment of an implanted stimulator according to the invention.
Figure 4A is a side view of the fixation device of the stimulator of Figure 4 in an expanded configuration with a removable replaceable battery unit coupled t o the electrode housing.
Figure 4B is a side view of the electrode housing and removable battery unit of the stimulator of Figure 4A.
Figure 5 is a schematic of an electrons c circuit of a stimulator according to an embodiment of the invention.
Figure 6 is a schematic of an external controller circuit according to an embodiment of the invention_ Detailed Description of the Invention:
Referring to Figures 1 and lA-1F a stimulator 30 in accordance with the invention is illustrated implanted in the gastrointestinal tract of a patient. The stimulator 30 comprises a fixation device 34 to be implant ed in the duodenum 24 and an electronics housing 50 to be located in the stomach 20 and coupled by wire tube 53 enclosing leads 51, 52, to the fixation device 34. The fixation device 34 includes electrodes 41, 42 in electrical contact with the duodenum 24 and the electronics housing 50 includes electronic circuitry 125 and a battery 144 that supply electrical stimulation pulses to the duodenum 24 through the electrodes 41, 42.
In Figure 1, the fixation device 34 is illustrated in place in the duodenum 24 located adjacent the pylorus 23 of a patient and above the duct 25 (where the ducts for bile and pancreatic secretions merge). The electrodes 41, 42 of the fixation device 34 are contained in an electrode housing 43 (Figure 1A) and exposed at the outer circumference of the fixation device 34 so that the electrodes 41, 42 may be positioned in electrical contact with the wall 27 of the duodenum 24. The fixation device 34 operates to engage the inner circumference of the wall 27 of the duodenum 24 to hold and maintain the electrodes 41, 42 in electrical contact with the duodenum 24. The fixation device 34 comprises a plurality of rings 36 including undulating members 37 having peaks and valleys that permit compression and expansion of the rings 36.
The rings 36 are preferably formed of Nitinol to provide spring-like properties with sufficient radial strength so that they may be compressed and constrained by a catheter containing the fixation device 34, and released from the catheter to expand into an expanded engaging position within a lumen of the gastrointestinal tract. The rings 36 define a common axis 39 extending through the rings 36. The rings 36 are attached to each other by way of the electrode housing 43, which is molded onto the rings 36 along the axis 39 of the rings 36. Each ring 36 is formed by a closed wire loop of undulating members 37 and includes a straight portion 38 over which the electrode housing 43 is molded. The electrode housing 43 may be formed of a biocompatible plastic such as polyurethane or polycarbonate. The fixation device 34 further defines a lumen 45 extending along the axis 39 through which materials from the stomach 20 may pass.
The fixation device 34 may delivered in a compressed configuration to the duodenum 24 through a catheter or the like, containing the fixation device 34 in its compressed state. The fixation device is then expanded into a configuration in which it engages the wall 27 of the duodenum 24. As illustrated in Figure 1A and 1B, in a compressed position, the diameter of the fixation device 3 4 is relatively small so that it can reside with within a catheter of sufficiently small diameter to be placed through upper gastrointestinal tract (i.e., into the mouth of a patient, through the esophagus and stomach, and through the pylorus into the duodenum). The catheter may include a retractable sheath containing the fixation device 34. The sheath is retractable upon locating the catheter in a desirable position for deployment of the fixation device 34 in the duodenum 24.
This may be guided by and endoscope or fluoroscopy. The fixation device 34 should be position in an ora d location from the duct 25 where the bile and pancreatic secretions empty into the duodenum 24 so that the fixation devic a 34 does not block the duct 25. When retracted, the sheath permits the self-expanding rings 36 of the fixation device 34 to expand to the expanded position illustrated in Figures 1C and 1D. Thus, when released from the catheter, the fixation device 34 expands to engage the inner circumference of the wall 27 of the duodenum 24. In its expanded position, the circumference of the fixation device 34 increases while the a lectrode housing 43 and the straight portion 38 of each ring 36 encased by the electrode housing 43 maintain their orig anal size and shape. The radial strength of the rings 36 serves to hold the fixation device 34 in place. The electrodes 41, 42 are located on the outer surface 44 of the electrode housing 43 and the rings 36 hold them in place against the wall 27 of the duodenum 24 to provide electrical contact therewith.
Alternatively, the rings 36 may be expandable by a balloon catheter or the like.
A pair of leads 51, 52 encased in a tube 53 extend out of the fixation device 34 and are coupled to the electronics housing 50. When the fixation device 34 is deployed, the tube 53 and electronics housing 50 extend in an orad direction, through the pylorus 23 and into the stomach 20. The electronics housing 50 is attached to the stomach 20 wall leaving sufficient slack in the tube 53 to allow for stomach contractions and movement. In this embodiment, the electronics housing 50 contains a battery 144 and electronic circuitry 125 (Figure 5) for providing electrical stimulation to the duodenum 24 through the leads 51, 52 extending thorough tubing 53 and coupled to the electrodes 41, 42. Figure 5 illustrates exemplary electronics 125 and battery 144 that may be used with the stimulator 30 or stimulators of other embodiments of the invention, such as, for example, those described herein. The electronics housing 50 a 1so includes a sensor 51 (or plurality of sensors) that may be provided with the capability of sensing one or more of various parameters of the gastrointestinal tract such as, e.g., pressure, temperature, pH, and relative movement (e.g., using an accelerometer).
The electronics housing 50 may be delivered into the stomach and coupled to the fixation device 34 in a number of manners. With the fixation device 34 in posit zon in the duodenum 24, the electronics housing 50 may be delivered to the stomach and attached to the fixation device through the wire tubing 53 extending between the stomach 20 and the duodenum 24 by connecting the wire tubing of a first portion 53a attached to the fixation device 34, to a second portion 53b of the wire tubing 53 coupled to the elect Tonics housing 50. The first portion 53a has a free end 54 with a connector 55 and an attached end 56 attached to the elec t rodes 41, 42 through the electrode housing 43 on the fixat ion device 34.
The second portion 53b includes an attached end 59 coupled to the electronics housing 50 and a free end 57 having a connector 58 that will mate with the connector 55 on the free end 54 of the first portion 53a to provide a connected electrical leads between the electrode housing 43 and the electronics housing 50. The electronics housing 50 is secured to the stomach wall with an attachment mechanism 52 and so that the tube 53 has sufficient slack to permit stomach churning, while not damaging or pulling the housing 50, fixation device 34 or tube 53. The attachment mechanism 52 prevents the housing 50 from moving through the pylorus 23.
The attachment mechanism 52 comprises an elongate flexible member 45 attached to the housing 50 and extending through the stomach wall and having a T-shaped end 46 that attaches the elongate member 45 to the stomach wall.
The electronics housing 50 may be delivered into the stomach and attached to the stomach wall using a needle into which the T-shaped end 46 is loaded. The needle pierces the stomach wall and releases the T-shaped end 46. The housing 50 is then attached to the fixation device 34 by using grasping tools extending through tool channels of an endoscope, to attach connectors 55 and 58. The electronics housing 50 may also be detached from the fixation device 34 through connectors 55, 58 so that the battery 144 and/or electronics125 may be replaced. While the electronics housing 50 and fixation device 34 are illustrated as being connected after the fixation device 34 and electrode housing 43 have been deployed, the electronics housing 50 may also be deployed through the catheter in a connected position with the fixation device before or after the fixation device 34 has been positioned and deployed. A catheter accommodating a needle to attach the attachment device 52 and a deployment mechanism for the fixation device 34 would need to be accommodated in a catheter designed for the multiple tasks involved.
The electronics housing 50 has a round smooth shape that will minimize any trauma to the stomach. The electronics housing 50 is also of a sufficient size that it will not be passed through pylorus 23 into the duodenum 24. It i s further constructed of a material that resists corrosion in the highly acidic stomach environment. Such corrosion resistant materials may include, for example, an acid corrosion resistant material such as a suitable inert polymer, for example, materials from the Polyolefin family like HDPE (high density polyethylene), LLDPE (linear low density polyethylene), and UHMwPE (ultra high molecular weight polyethylene); fluoropolymer materials like PTFET"" (poly tetrafluoroethylene) , FEPT"" (fluorinated ethylene propylene) and others; polymethylpentene, and polysulphons; some elastomers such as thermoplastic polyurethanes and C- Flex type block copolymers that are stable in acidic environments.
Additionally the electronics housing 50 may be constructed of an acid corrosion resistant metal such as Platinum, Gold, Tantalum, Titanium, or suitable alloys thereof.
Referring to Figure 5, the electronics 125 and battery 144 are illustrated that may be used with the various embodiments of the stimulator described herein. The electronic circuitry may be on a chip or otherwise have a standard configuration that may be used in a number of different embodiments of the stimulator device. In general, the electronic circuitry includes a controller that delivers electrical stimulation pulses through the electrodes to the wall of the duodenum, the stimulation tends to cause the pylorus 23 to close. The stimulation may be actuated by a user upon ingesting food and the stimulation may continue for a predetermined period of time thereafter. In one embodiment the stimulation parameters are preprogrammed into the controller. The stimulation device may also be provided with the capability of sensing various parameters of the gastrointestinal tract such as, e.g., pressure, temperature and relative movement (e.g., using an accelerometer). The parameters may be used to determine various conditions, for example, patient is awake, sleeping and the type, period, or other parameters of stimulation may be modified according to a program or by a user or health care provider. The electronic circuitry 125 of the stimulator is located in the stimulator housings of the various implants described herein such as, for example, a subcutaneously implanted stimulator unit; a stimulator unit included with the fixation device; a removable attachable housing that may be attached to the fixation device; or in a another housing located within the gastrointestinal tract (e.g., the stomach) and attached by way of leads to the fixation device. Likewise, the battery 144 that powers the electronic circuitry 125 may be located in a number of different housings in various embodiments and configurations of the stimulator. In these different locations, the battery 144 may be removable and replaceable with the electronic circuitry 125 or own its own in a modular device. If the stimulator is included with the fixation device, the battery may also be removably and replaceably attachable to the electronics or electrode housing on the fixation device. The battery 144 may be located with the electronic circuitry 125 attached by way of leads t o the stimulator.
The stimulation of the duodenum occurs for a predetermined period of time after which the stimulation is discontinued to allow emptying of the stomach. The circuitry 125 of one embodiment as illustrated in Figure 5 comprises: a microprocessor or controller 140 for controlling the operations of the electronic circuitry 125, and an internal clock 141. The circuitry 125 may also include a battery device 144 such as a pair of lithium iodine batteries for powering the various components of the circuitry 125.
Alternatively, the battery device 144 may be housed in a separate unit that may be coupled to the circuitry 125. As such, the controller 140 and battery device 144 are coupled t o each of the major components of the circuit as would be apparent to one of ordinary skill in the art. The controller 140 is coupled to stimulation driver 142, which is coupled to stimulating electrodes 41, 42 (or any of the other electrode ~
l0 described herein) that are used to provide electrical stimulation in accordance with programmed parameters.
The controller 140 is coupled to ROM 143, which contains the program instructions for the controller 140 and any other permanently stored information that allows the microprocessor/controller 140 to operate. The controller 140 addresses memory in ROM 143 through address bus 143a and the ROM 143 provides the stored program instruction to the controller 140 via data bus 143b. The controller 140 control s the RF coil 145, which communicates with an external control or programming device 160 (Figure 6), preferably via a modulated RF signal. Processor 140 is coupled to a buffered oscillator 151 that provides an RF signal to be emitted from the RF coil 145. The RF signal is preferably at about 100kHz to 5MHz so that the signal is efficiently transmitted through tissue. The controller 140 controls the oscillator 151 and may provide data to be modulated with the RF signal to be delivered through the RF coil 145. Such data may include, for example, data sensed by a sensor 51 located on the electronic s housing 50 (or alternatively the fixation device 34), such as pressure, pH, temperature, movement (accelerometer), or sensed electrical information such as impedance, electrical activity (EMG) etc. One or more sensors 147a (e. g., accelerometer), 147b (e.g., pressure), 147c (e.g., pH), 147d temperature, or electrodes 41, 42 (for sensing EMG, EGG, or impedance as well as providing stimulation), may be coupled to the controller 140 through A/D converters (with amplifiers) 146a, 146b, 1 46c, 146d, 146e which convert a representative analog electrical signal into a digital signal. Suitable types of these sensors are generally known in the art and may be located within, on, or external to the electronics housing 50, fixation device 34 or electrode housing 43 on the fixation device 44. When the RF coil 145 is receiving an external telemetry signal, the buffered oscillator 151 is disabled. Telemetry signals received on the RF coil 145 are detected in a detector circuit 151a and to communicated controller 140. The detector circuit 151a is preferably selected based on the modulation used f or telemetry signals. The sensed parameters may indicate e.g.
the ingestion of food or activity level of a patient. Pacing may be turned on or off based on these parameters.
Controller 140 is coupled to RAM 150 via an address bus 150a for addressing a location in RAM 150 and a bi-directz onal data bus 150b for delivering information to and from RAM 1 50.
The RAM 150 includes event memory 148 that temporarily st ores data recorded by sensors 147a-d or electrodes 41, 42 (or other electrode pairs described herein). RAM 150 also includes a programmable memory 149 which may be programmed, for example, by an external programmer 160. The data stored in the programmable memory may include specifications for the electrical stimulation operating modes or parameters. Such programming may be done in response to sensed information or it may be done automatically by an external controller or as desired by a treating physician, etc. Sensed data acquired from sensors 147a-d and electrodes 41, 42 or other electrode pairs described herein, provided to the controller 140 may be stored in event memory 148 in the RAM 150. The data stored in the event memory 148, may be sent intermittently as data bursts via the RF coil 145, as opposed to continuously in order to save battery power.
The electrode 41, 42 outputs are used to provide electrical stimulation delivered through the stimulation driver 142 to the 41, 42. The stimulation modes and parameters may be pre-programmed or may be set using the external programmer 160 or in response to sensory feedback.
The same electrode outputs may be used to sense impedance through impedance circuit 153 and to sense electrical activity, which is delivered through A/D converter 146e. The, electrodes 41, 42 are coupled through coupling capacitors 155a and 155b respectively, to the output of electrical stimulation driver 142 and the inputs of A/D converters 146e, 146f.
The impedance circuit 153 comprises a constant current source oscillator 154 that oscillates at a frequency of 50-100kHz, and an A/D converter 146f coupled to the control ler 140. The oscillator 154 provides a constant current source through electrodes 41, 42 resulting in a voltage across the electrodes 41, 42 that is representative of impedance, in view of the constant current. The voltage is provided through and is converted by A/D converter 146f to a digital signal representative of impedance. A/D converter 146f has a bandwidth that includes the 50kHz frequency signal while filtering out the electrical stimulation signal that is delivered to the electrodes 41, 42 through electrical stimulation driver 142, and the EMG signal that is sensed by the electrodes 41, 42. Both of the outputs are filtered out by A/D converter 146f. A/D converter 146e has a bandwidth that filters out the 50-100kHz signal. Further, when a stimulation signal is being delivered, the controller 140 does not receive signals from A/D converters 146e and 146f. Thus the EMG and impedance sensing functions and the stimulation delivery functions are separated through the electronic circuitry 125, though using the same electrodes.
The battery 144 has its output supplied to a DC-to-DC
converter 144a to provide a higher voltage, which is utili zed for electrical stimulation pulses. The DC-to-DC converter 144a is conventional and provides an output voltage of 15 to 20 volts.
Figure 6 illustrates the electronic circuitry 163 for external programmer 160. The electronic circuitry 163 comprises: a microprocessor or controller 170 for controlling the operations of the electronic circuitry, an internal clocl~
171, and a power source 174 such as a battery device for powering the various components of the circuit 163. As such, l0 the controller 170 and battery device 174 are coupled to each of the major components of the circuit as would be apparent t o one of ordinary skill in the art. The controller 170 may be coupled to a speaker 167 for that provides audible alerts and a display 166 such as a CRT to display data such as recorded data, sensed parameters, treatment parameters and status of the device (e.g. position or battery charge status). The controller 170 is coupled through a buffer 164 to external input device 165 that is used to provide program parameter input, e.g. from a user, for a user to request data displayed in a desired format through display 166 or speaker 167, or to turn the device on and off. The external programmer 160 is also provided with an external data port 168 to interface wit h a computer and provide a means for bi-directional communication of data or commands. The computer may provide programming or data to the controller/microprocessor 170. A
user may also interface with the computer to provide treatmen t protocols or changes in protocols, etc. Also, a user may control the turning on and off of the stimulation program.
The controller 170 is coupled to ROM 173, which contains the program instructions for the controller 170 and any other permanently stored information that allows the microprocessor/controller to operate. The controller 170 addresses memory in ROM 173 through address bus 173a and the ROM 173 provides the stored program instructions to the controller 170 via data bus 173b. The controller 170 controls the RF coil 175, which communicates with stimulator electronic circuitry 125 (Figure 5) through its RF coil 145. Processor 170 is coupled to an oscillator 172 that provides an RF
signal, preferably having a characteristic frequency of 500kHz or higher, to be emitted from the RF coil 175. The controller 170 controls the oscillator 172 and provides data to be modulated with the RF signal, for example, programming information, stimulation parameters, etc. The RF coil 175 also receives information transmitted via RF signal from RF
coil 145 on the stimulator electronic circuitry 125 such as various sensed data, e.g., pressure, pH, impedance, electrical activity (EMG) etc. The received RF signal is passed through demodulator 176 and is transmitted to the controller 170. The data is delivered to the event memory 178 in RAM 17'7 by way of data bus 177b for temporary storage. The data may be retrieved from RAM 177 by addressing the storage location via the address bus 177a.
Event memory 178 temporarily stores data recorded by sensors 147a-147 and electrodes 41, 42 and delivered via telemetry to the external programmer 160, until the data is downloaded onto a computer using the external data port 168.
The RAM 177 also includes a programmable memory 179 which may be programmed, for example, to specify operating modes such as waveform, frequency, etc. which programming is then telemetrically communicated to the stimulator electronic circuitry 125. The modes and parameters can either be set using an external programmer 160 or set in response to sensory feedback.
In an alternative embodiment, the device includes a housing, electrodes and minimal electronics and an electromagnetic coil. This device is powered by an external electromagnetic coil, which is placed on the patient's abdomen near the implanted device. The electrical stimulati on parameters are controlled real-time by an external unit.
Referring to Figure 2, an alternative stimulator 70 having an alternative electronics/electrode housing 73 is illustrated. The stimulator 70 comprises a fixation device 75 with a housing 73 for the electrodes 81, 82. The fixation device 75 is similar to fixation device 34 described above with reference to Figures 1-1F. The housing 73 in this embodiment also contains the electronics 125. The electrodes 81, 82 are coupled to the electronic circuitry 125 by way of connectors 83, 84. The electronic circuitry 125 is coupled to leads 76, 77 encased in corrosion resistant wire tubing 78 that extends out of the housing 73 and fixation device 75.
When the stimulation device 70 is deployed in the duodenum 24, wire tubing 78 similarly extends out of the duodenum 24 in an orad direction, through the pylorus 23 and into the stomach 20 where it is coupled to the battery 144 contained in a battery housing. The fixation device 75 is placed in the duodenum 24 in a manner similar to fixation device 34 described above with reference to Figures 1-1F. The battery housing 74 is configured similarly to the electronics housing 50 of Figures 1-1F of a corrosion resistant material and rounded configuration, with the battery 144 but without the electronic circuitry 125. The battery 144 is electrically coupled through leads 76, 77 to the electronic circuitry 125 located in the housing 73. The battery housing 74 is removable and replaceable in a manner similar to electronics housing 50 described above with reference to Figures 1-1F and the stimulation programming and protocol may be delivered in a similar manner as well.
Referring to Figure 3 an alternative stimulator 30' is illustrated comprising a fixation device 34' implanted in a duodenum 24 in a similar manner as fixation device 34 described above with reference to Figures 1-1F. In this embodiment however, the wire tubing 53' extends out of the wall 27 of the duodenum 24, into the abdominal cavity 28 where it is coupled to electronics housing 50' containing tha electronics unit 125 and battery 144. In implanting the stimulator 30', the fixation device 34' is placed in the duodenum 24 and the electronics housing 50' is implanted subcutaneously within the abdominal cavity 28. The wire tubing 53' coupled to and extending from the electronic s housing 50' is then laparoscopically placed through the abdomen and through the wall 27 of the duodenum 24 where it is coupled through connector 44' to the electrodes 41', 42' encased in the electrode housing 43'. The stimulation is provided from the electronic circuitry 125 to the inner wall of the duodenum 24 wall in a manner similar to that described above with reference to Figures 1-1F, 5 and 6.
Referring to Figure 3 an alternative stimulator 30' is illustrated comprising a fixation device 34' implanted in a duodenum 24 in a similar manner as fixation device 34 described above with reference to Figures 1-1F. In thi s embodiment however, the wire tubing 53' extends out of the wall 27 of the duodenum 24, into the abdominal cavity 2 8 where it is coupled to electronics housing 50' containing the electronics unit 125 and battery 144. In implanting the stimulator 30', the fixation device 34' is placed in the duodenum 24 and the electronics housing 50' is implante d subcutaneously within the abdominal cavity 28. The wir a tubing 53' coupled to and extending from the electronic s housing 50' is then laparoscopically placed through the abdomen and through the wall 27 of the duodenum 24 whey a it is coupled through connector 44' to the electrodes 41', 42' similarly encased in the electrode housing 43' as elect rodes 41, 42 are encased in housing 43 with reference to Figures l, and 1A-1F. The stimulation is provided from the electronic circuitry 125 to the inner wall of the duodenum 24 wall in a manner similar to that described above with reference to Figures 1-1F, 5 and 6.
Referring to Figures 4, and 4A-4B, an alternative embodiment of the invention is illustrated. A stimulator 90 comprises a fixation device 93 including an electronics housing 94 with electrodes 91, 92 and electronic circuitry 125 coupled to the electrodes 91, 92. The electronic circuitry 125 is powered by battery 144 contained in a removable battery housing 95 that is configured to be removably coupled to the fixation device 93 in electrical communication with the electronics unit 125 contained in the electronics housing 94.
In particular, the battery housing 95 includes magnets 98, 99 that may be coupled with magnets 104, 105 on the inner wall 106 of the electronics housing 94. Electrical contacts 96, 97 on the battery housing 95 align with electrical contacts 102, 103 on the inner wall 106 of the electronics housing 94 when the magnets 98, 99 are correspondingly aligned with magnets 104, 105 on the electronics housing 94. When the magnets 98, 99 are aligned with magnets 104, 105 and the battery housing is coupled to the electronics housing 94, contacts 96, 97 are correspondingly electrically coupled to contacts 102, 103 so that the battery 144 provides power to the electronic circuitry 125 among other things, to deliver stimulating pulses to the duodenum 24 as described herein with reference to Figures 5 and 6.
While the invention has been described with reference to particular embodiments, it will be understood to one skilled in the art that variations and modifications may be made in form and detail without departing from the spirit and scope of the invention.
a fixation device comprising a radially expandable member; an outer portion; and at least one electrode coupled to the outer portion of the fixation device, wherein the radially expandable member is configured to fix the fixation device within a portion of the gastrointestinal tract so that the at least one electrode is in electrical contact with the gastrointestinal tract.
an attachment device coupled to the housing and configured to attach the housing to the stomach wall.
a fixation device comprising at least one electrode coupled to the fixation device, wherein the fixation device is configured to be positioned within a portion of an intestinal tract so that the at least one electrode is in electrical contact with the intestinal tract;
an electronic housing configured to b a positioned in the stomach; and at least one lead electrically couple d to the at least one electrode and configured to extend from the fixation device in the intestinal tract into the stomach and to be coupled to the electronics housing;
wherein the electronics housing comprises electronics unit configured to supply electrical stimulation pulses through the lead to the at least one electrode.
an attachment device coupled to the housing and configured to attach the housing to the stomach wall.
providing a stimulator comprising:
a fixation device;
at least one electrode coupled to the fixation device; and electronic circuitry coupled to the at least one electrode and configured to deliver electrical stimulation through the at least one electrode;
positioning the fixation device in the duodenum of a patient so that the at least one stimulating electrode is in electrical contact with the wall of the duodenum;
providing stimulation pulses from the electronic circuitry to the duodenum through the at least one electrode and thereby affecting the contraction of the pylorus.
providing electrical stimulation to the duodenum of a patient to control the contraction of the pylorus.
providing a stimulator comprising:
a fixation device;
at least one electrode coupled to the fixation device; and electronic circuitry coupled to the at least one electrode and configured t o deliver electrical stimulation through the at least one electrode;
positioning the fixation device in the duodenum of a patient so that the at least one stimulating electrode is in electrical contact with the wall of the duodenum; and providing stimulation pulses from the electronic circuitry to the duodenum through the at least one electrode and thereby affecting the contraction of the pylorus.
Priority Applications (3)
|Application Number||Priority Date||Filing Date||Title|
|US10691735 US7054690B2 (en)||2003-10-22||2003-10-22||Gastrointestinal stimulation device|
|PCT/US2004/033210 WO2005041749A3 (en)||2003-10-22||2004-10-07||Gastrointestinal stimulation device|
|Publication Number||Publication Date|
|CA2543209A1 true true CA2543209A1 (en)||2005-05-12|
Family Applications (1)
|Application Number||Title||Priority Date||Filing Date|
|CA 2543209 Abandoned CA2543209A1 (en)||2003-10-22||2004-10-07||Gastrointestinal stimulation device|
Country Status (4)
|US (4)||US7054690B2 (en)|
|CA (1)||CA2543209A1 (en)|
|EP (1)||EP1682216A4 (en)|
|WO (1)||WO2005041749A3 (en)|
Families Citing this family (166)
|Publication number||Priority date||Publication date||Assignee||Title|
|US8666495B2 (en)||1999-03-05||2014-03-04||Metacure Limited||Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar|
|US9101765B2 (en)||1999-03-05||2015-08-11||Metacure Limited||Non-immediate effects of therapy|
|ES2435094T3 (en)||2000-05-19||2013-12-18||C.R. Bard, Inc.||Device and method for capturing and suture tissue|
|US8467874B2 (en) *||2000-04-11||2013-06-18||The Board Of Regents Of The University Of Texas System||Gastrointestinal electrical stimulation|
|US8761903B2 (en) *||2000-10-11||2014-06-24||The Board Of Regents Of The University Of Texas||Gastrointestinal electrical stimulation|
|EP1272250A4 (en) *||2000-04-11||2003-07-09||Univ Texas||Gastrointestinal electrical stimulation|
|US7737109B2 (en) *||2000-08-11||2010-06-15||Temple University Of The Commonwealth System Of Higher Education||Obesity controlling method|
|WO2002013854A1 (en) *||2000-08-11||2002-02-21||Temple University Of The Commonwealth System Of Higher Education||Obesity controlling method|
|US6600953B2 (en)||2000-12-11||2003-07-29||Impulse Dynamics N.V.||Acute and chronic electrical signal therapy for obesity|
|CN100366310C (en) *||2001-01-05||2008-02-06||超治疗股份有限公司||Regulation of eating habits|
|JP4246998B2 (en) *||2001-04-18||2009-04-02||インパルス ダイナミックス エヌヴィ||Analysis of eating habits|
|US7979127B2 (en) *||2001-05-01||2011-07-12||Intrapace, Inc.||Digestive organ retention device|
|WO2007047411A3 (en) *||2005-10-12||2007-09-20||Intrapace Inc||Systems and devices for stimulating an organ wall|
|US7702394B2 (en)||2001-05-01||2010-04-20||Intrapace, Inc.||Responsive gastric stimulator|
|US7338433B2 (en)||2002-08-13||2008-03-04||Allergan, Inc.||Remotely adjustable gastric banding method|
|DE60331457D1 (en)||2002-08-28||2010-04-08||Allergan Inc||Fatigue-resistant gastric belt device|
|US7678068B2 (en)||2002-12-02||2010-03-16||Gi Dynamics, Inc.||Atraumatic delivery devices|
|US7608114B2 (en)||2002-12-02||2009-10-27||Gi Dynamics, Inc.||Bariatric sleeve|
|CA2512203C (en)||2002-12-02||2012-10-23||Gi Dynamics, Inc.||Bariatric sleeve|
|US7025791B2 (en) *||2002-12-02||2006-04-11||Gi Dynamics, Inc.||Bariatric sleeve|
|US7695446B2 (en)||2002-12-02||2010-04-13||Gi Dynamics, Inc.||Methods of treatment using a bariatric sleeve|
|US7444183B2 (en) *||2003-02-03||2008-10-28||Enteromedics, Inc.||Intraluminal electrode apparatus and method|
|US7613515B2 (en) *||2003-02-03||2009-11-03||Enteromedics Inc.||High frequency vagal blockage therapy|
|US7844338B2 (en)||2003-02-03||2010-11-30||Enteromedics Inc.||High frequency obesity treatment|
|US20040172084A1 (en)||2003-02-03||2004-09-02||Knudson Mark B.||Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)|
|EP1610719B1 (en) *||2003-03-28||2010-01-13||GI Dynamics, Inc.||Sleeve for delayed introduction of enzymes into the intestine|
|US20040220682A1 (en) *||2003-03-28||2004-11-04||Gi Dynamics, Inc.||Anti-obesity devices|
|US8792985B2 (en)||2003-07-21||2014-07-29||Metacure Limited||Gastrointestinal methods and apparatus for use in treating disorders and controlling blood sugar|
|US8048169B2 (en) *||2003-07-28||2011-11-01||Baronova, Inc.||Pyloric valve obstructing devices and methods|
|US8821521B2 (en) *||2003-07-28||2014-09-02||Baronova, Inc.||Gastro-intestinal device and method for treating addiction|
|US20090259236A2 (en) *||2003-07-28||2009-10-15||Baronova, Inc.||Gastric retaining devices and methods|
|US9700450B2 (en)||2003-07-28||2017-07-11||Baronova, Inc.||Devices and methods for gastrointestinal stimulation|
|US9498366B2 (en) *||2003-07-28||2016-11-22||Baronova, Inc.||Devices and methods for pyloric anchoring|
|US7054690B2 (en) *||2003-10-22||2006-05-30||Intrapace, Inc.||Gastrointestinal stimulation device|
|CA2588727C (en) *||2003-11-28||2014-01-14||University Technologies International Inc.||Gastrointestinal motility control|
|US8057420B2 (en)||2003-12-09||2011-11-15||Gi Dynamics, Inc.||Gastrointestinal implant with drawstring|
|EP1708641A1 (en)||2003-12-09||2006-10-11||GI Dynamics, Inc.||Intestinal sleeve|
|EP2399528B1 (en)||2004-01-23||2013-01-09||Allergan, Inc.||Releasably-securable one-piece adjustable gastric band|
|US8588930B2 (en) *||2005-06-07||2013-11-19||Ethicon, Inc.||Piezoelectric stimulation device|
|US8751003B2 (en)||2004-02-11||2014-06-10||Ethicon, Inc.||Conductive mesh for neurostimulation|
|US7979137B2 (en)||2004-02-11||2011-07-12||Ethicon, Inc.||System and method for nerve stimulation|
|US7931693B2 (en) *||2004-02-26||2011-04-26||Endosphere, Inc.||Method and apparatus for reducing obesity|
|US8147561B2 (en)||2004-02-26||2012-04-03||Endosphere, Inc.||Methods and devices to curb appetite and/or reduce food intake|
|US8585771B2 (en) *||2004-02-26||2013-11-19||Endosphere, Inc.||Methods and devices to curb appetite and/or to reduce food intake|
|US9060835B2 (en)||2006-05-26||2015-06-23||Endosphere, Inc.||Conformationally-stabilized intraluminal device for medical applications|
|WO2005087147A1 (en)||2004-03-08||2005-09-22||Endoart S.A.||Closure system for tubular organs|
|US20050209653A1 (en) *||2004-03-16||2005-09-22||Medtronic, Inc.||Intra-luminal device for gastrointestinal electrical stimulation|
|US9821158B2 (en)||2005-02-17||2017-11-21||Metacure Limited||Non-immediate effects of therapy|
|US8236023B2 (en)||2004-03-18||2012-08-07||Allergan, Inc.||Apparatus and method for volume adjustment of intragastric balloons|
|EP1768618B1 (en) *||2004-07-09||2011-04-20||GI Dynamics, Inc.||Devices for placing a gastrointestinal sleeve|
|US8612016B2 (en) *||2004-08-18||2013-12-17||Metacure Limited||Monitoring, analysis, and regulation of eating habits|
|EP1799145B1 (en)||2004-09-17||2016-12-21||GI Dynamics, Inc.||Gastrointestinal anchor|
|US20060089709A1 (en) *||2004-10-21||2006-04-27||Helmus Michael N||Medical implant with average surface charge density|
|WO2006068970A3 (en) *||2004-12-21||2007-01-18||Mitchell Roslin||Anastomotic outlet revision|
|US7771382B2 (en) *||2005-01-19||2010-08-10||Gi Dynamics, Inc.||Resistive anti-obesity devices|
|US7766973B2 (en) *||2005-01-19||2010-08-03||Gi Dynamics, Inc.||Eversion resistant sleeves|
|EP1890763A4 (en) *||2005-06-02||2017-05-03||Metacure Ltd||Gi lead implantation|
|WO2007080595A3 (en) *||2006-01-12||2009-04-16||Yuval Elovici||Electrode assemblies, tools, and methods for gastric wall implantation|
|US8251888B2 (en)||2005-04-13||2012-08-28||Mitchell Steven Roslin||Artificial gastric valve|
|US20060282107A1 (en) *||2005-05-09||2006-12-14||Kiyoshi Hashiba||Intragastric device for treating obesity|
|US7976488B2 (en)||2005-06-08||2011-07-12||Gi Dynamics, Inc.||Gastrointestinal anchor compliance|
|JP2008545508A (en)||2005-06-10||2008-12-18||ウィルソン−クック・メディカル・インコーポレーテッドＷｉｌｓｏｎ−Ｃｏｏｋ Ｍｅｄｉｃａｌ Ｉｎｃｏｒｐｏｒａｔｅｄ||Ablation catheter|
|US7822486B2 (en) *||2005-08-17||2010-10-26||Enteromedics Inc.||Custom sized neural electrodes|
|US7672727B2 (en) *||2005-08-17||2010-03-02||Enteromedics Inc.||Neural electrode treatment|
|US7616996B2 (en) *||2005-09-01||2009-11-10||Intrapace, Inc.||Randomized stimulation of a gastrointestinal organ|
|US8442841B2 (en)||2005-10-20||2013-05-14||Matacure N.V.||Patient selection method for assisting weight loss|
|US20090234417A1 (en) *||2005-11-10||2009-09-17||Electrocore, Inc.||Methods And Apparatus For The Treatment Of Metabolic Disorders|
|US8295932B2 (en) *||2005-12-05||2012-10-23||Metacure Limited||Ingestible capsule for appetite regulation|
|CA2634614C (en) *||2005-12-22||2011-07-26||Wilson-Cook Medical Inc.||Coiled intragastric member for treating obesity|
|US8216268B2 (en) *||2005-12-22||2012-07-10||Cook Medical Technologies Llc||Intragastric bag for treating obesity|
|US8043206B2 (en)||2006-01-04||2011-10-25||Allergan, Inc.||Self-regulating gastric band with pressure data processing|
|US7798954B2 (en)||2006-01-04||2010-09-21||Allergan, Inc.||Hydraulic gastric band with collapsible reservoir|
|US20070198039A1 (en) *||2006-01-27||2007-08-23||Wilson-Cook Medical, Inc.||Intragastric device for treating obesity|
|ES2545687T3 (en) *||2006-02-03||2015-09-15||Baronova, Inc.||gastrointestinal device|
|US20090157138A1 (en) *||2006-04-18||2009-06-18||Electrocore, Inc.||Methods And Apparatus For Treating Ileus Condition Using Electrical Signals|
|US20100057178A1 (en) *||2006-04-18||2010-03-04||Electrocore, Inc.||Methods and apparatus for spinal cord stimulation using expandable electrode|
|US20080183237A1 (en) *||2006-04-18||2008-07-31||Electrocore, Inc.||Methods And Apparatus For Treating Ileus Condition Using Electrical Signals|
|US7558629B2 (en) *||2006-04-28||2009-07-07||Medtronic, Inc.||Energy balance therapy for obesity management|
|US20070255154A1 (en) *||2006-04-28||2007-11-01||Medtronic, Inc.||Activity level feedback for managing obesity|
|US9020597B2 (en)||2008-11-12||2015-04-28||Endostim, Inc.||Device and implantation system for electrical stimulation of biological systems|
|US8160709B2 (en)||2006-05-18||2012-04-17||Endostim, Inc.||Use of electrical stimulation of the lower esophageal sphincter to modulate lower esophageal sphincter pressure|
|US7894906B2 (en) *||2006-06-06||2011-02-22||Cardiac Pacemakers, Inc.||Amelioration of chronic pain by endolymphatic stimulation|
|US7734341B2 (en) *||2006-06-06||2010-06-08||Cardiac Pacemakers, Inc.||Method and apparatus for gastrointestinal stimulation via the lymphatic system|
|US20070282376A1 (en) *||2006-06-06||2007-12-06||Shuros Allan C||Method and apparatus for neural stimulation via the lymphatic system|
|US8126538B2 (en) *||2006-06-06||2012-02-28||Cardiac Pacemakers, Inc.||Method and apparatus for introducing endolymphatic instrumentation|
|US7899541B2 (en) *||2006-06-20||2011-03-01||Ebr Systems, Inc.||Systems and methods for implantable leadless gastrointestinal tissue stimulation|
|US7819836B2 (en) *||2006-06-23||2010-10-26||Gi Dynamics, Inc.||Resistive anti-obesity devices|
|US20080004671A1 (en) *||2006-06-28||2008-01-03||Alza Corporation||Vagus nerve stimulation via orally delivered apparatus|
|US7509175B2 (en) *||2006-08-03||2009-03-24||Intrapace, Inc.||Method and devices for stimulation of an organ with the use of a transectionally placed guide wire|
|EP2056741A2 (en) *||2006-08-23||2009-05-13||Svip 2 LLC||Devices and methods for altering eating behavior|
|US8905999B2 (en) *||2006-09-01||2014-12-09||Cardiac Pacemakers, Inc.||Method and apparatus for endolymphatic drug delivery|
|EP2258277A1 (en) *||2006-10-04||2010-12-08||NDO Surgical, Inc.||System for gastric restriction|
|US9345879B2 (en)||2006-10-09||2016-05-24||Endostim, Inc.||Device and implantation system for electrical stimulation of biological systems|
|US7738961B2 (en) *||2006-10-09||2010-06-15||Endostim, Inc.||Method and apparatus for treatment of the gastrointestinal tract|
|US9724510B2 (en)||2006-10-09||2017-08-08||Endostim, Inc.||System and methods for electrical stimulation of biological systems|
|US20080103577A1 (en) *||2006-10-31||2008-05-01||Medtronic, Inc.||Implantable medical elongated member including a tissue receiving fixation cavity|
|WO2008096362A1 (en) *||2007-02-07||2008-08-14||Duocure, Inc.||Duodenal stimulation devices and methods for the treatment of conditions relating to eating disorders|
|WO2008100974A3 (en) *||2007-02-13||2009-12-30||Sharma Virender K||Method and apparatus for electrical stimulation of the pancreatico-biliary system|
|US8801647B2 (en) *||2007-02-22||2014-08-12||Gi Dynamics, Inc.||Use of a gastrointestinal sleeve to treat bariatric surgery fistulas and leaks|
|US9364666B2 (en) *||2007-05-07||2016-06-14||Transtimulation Research, Inc.||Method of using a gastrointestinal stimulator device for digestive and eating disorders|
|US20080281375A1 (en) *||2007-05-07||2008-11-13||Transtimulation Research, Inc.||Gastrointestinal stimulator device for digestive and eating disorders|
|US8007507B2 (en) *||2007-05-10||2011-08-30||Cook Medical Technologies Llc||Intragastric bag apparatus and method of delivery for treating obesity|
|US20080294228A1 (en) *||2007-05-23||2008-11-27||Cardiac Pacemakers||Method and device for controlled stimulation of lymphatic flow|
|EP2157936A2 (en) *||2007-06-04||2010-03-03||Svip 8 Llc||Tissue anchorable devices|
|EP2303390A4 (en) *||2008-06-03||2011-11-30||Svip 8 Llc||Tissue-anchored devices|
|EP2170458A1 (en) *||2007-06-13||2010-04-07||E- Pacing, Inc.||Implantable devices and methods for stimulation of cardiac or other tissues|
|WO2008157180A1 (en) *||2007-06-13||2008-12-24||E-Pacing, Inc.||Implantable devices and methods for stimulation of cardiac and other tissues|
|US8032222B2 (en)||2007-06-19||2011-10-04||Loushin Michael K H||Device for electrically and mechanically stimulating a compartment in a body|
|US20110137227A1 (en) *||2007-07-16||2011-06-09||Mckinley James T||Methods and devices for delivering or delaying lipids within a duodenum|
|US8855770B2 (en) *||2007-07-24||2014-10-07||Betastim, Ltd.||Duodenal eating sensor|
|US7930033B2 (en) *||2007-08-17||2011-04-19||Jianfeng Chen||Appendicular and rectal stimulator device for digestive and eating disorders|
|US8888797B2 (en) *||2007-09-07||2014-11-18||Baronova, Inc.||Device for intermittently obstructing a gastric opening and method of use|
|US8301265B2 (en)||2007-09-10||2012-10-30||Medtronic, Inc.||Selective depth electrode deployment for electrical stimulation|
|US9707392B2 (en) *||2007-10-05||2017-07-18||Uti Limited Partnership||Feedback controlled gastro-intestinal stimulation|
|US20090149879A1 (en) *||2007-12-10||2009-06-11||Dillon Travis E||Dynamic volume displacement weight loss device|
|US8099446B2 (en) *||2007-12-12||2012-01-17||International Business Machines Corporation||Digital content searching tool|
|US7883524B2 (en) *||2007-12-21||2011-02-08||Wilson-Cook Medical Inc.||Method of delivering an intragastric device for treating obesity|
|US8016851B2 (en) *||2007-12-27||2011-09-13||Cook Medical Technologies Llc||Delivery system and method of delivery for treating obesity|
|WO2009094609A1 (en)||2008-01-25||2009-07-30||Sharma Virender K||Device and implantation system for electrical stimulation of biological systems|
|US8192350B2 (en) *||2008-01-28||2012-06-05||Ethicon Endo-Surgery, Inc.||Methods and devices for measuring impedance in a gastric restriction system|
|US8565885B2 (en) *||2008-01-30||2013-10-22||The Board Of Regents Of The University Of Texas System||Ileal electrical stimulation|
|US8326439B2 (en)||2008-04-16||2012-12-04||Nevro Corporation||Treatment devices with delivery-activated inflatable members, and associated systems and methods for treating the spinal cord and other tissues|
|US8494623B2 (en) *||2008-06-09||2013-07-23||The Board Of Trustees Of The Leland Stanford Junior University||Method and apparatus for in-vivo physiological monitoring|
|EP2362762A1 (en)||2008-10-06||2011-09-07||Allergan Medical Sàrl||Mechanical gastric band with cushions|
|US8195297B2 (en) *||2008-10-13||2012-06-05||E-Pacing, Inc.||Devices and methods for electrical stimulation of the diaphragm and nerves|
|US20100185049A1 (en)||2008-10-22||2010-07-22||Allergan, Inc.||Dome and screw valves for remotely adjustable gastric banding systems|
|WO2010075482A8 (en) *||2008-12-27||2011-11-17||John Hancock||High specific gravity intragastric device|
|US20100268297A1 (en) *||2009-02-24||2010-10-21||Hans Neisz||Duodenal Stimulation To Induce Satiety|
|WO2010125570A1 (en) *||2009-04-30||2010-11-04||Svip 2 Llc||Devices and methods for treating gastrointestinal and metabolic disorders|
|US20110004288A1 (en) *||2009-06-12||2011-01-06||Terrance Ransbury||Intravascular implantable device having integrated anchor mechanism|
|CA2773868A1 (en)||2009-09-10||2011-03-17||Intrapace, Inc.||Improved diagnostic sensors and/or treatments for gastrointestinal stimulation or monitoring devices|
|US8934975B2 (en)||2010-02-01||2015-01-13||Metacure Limited||Gastrointestinal electrical therapy|
|US8758221B2 (en)||2010-02-24||2014-06-24||Apollo Endosurgery, Inc.||Source reservoir with potential energy for remotely adjustable gastric banding system|
|US8840541B2 (en)||2010-02-25||2014-09-23||Apollo Endosurgery, Inc.||Pressure sensing gastric banding system|
|DE212011100038U1 (en)||2010-03-05||2012-07-17||Endostim, Inc.||Device and implantation system for electrical stimulation of biological systems|
|US9044298B2 (en)||2010-04-29||2015-06-02||Apollo Endosurgery, Inc.||Self-adjusting gastric band|
|US20110270024A1 (en)||2010-04-29||2011-11-03||Allergan, Inc.||Self-adjusting gastric band having various compliant components|
|US9028394B2 (en)||2010-04-29||2015-05-12||Apollo Endosurgery, Inc.||Self-adjusting mechanical gastric band|
|US20110270025A1 (en)||2010-04-30||2011-11-03||Allergan, Inc.||Remotely powered remotely adjustable gastric band system|
|US8517915B2 (en)||2010-06-10||2013-08-27||Allergan, Inc.||Remotely adjustable gastric banding system|
|US8825164B2 (en)||2010-06-11||2014-09-02||Enteromedics Inc.||Neural modulation devices and methods|
|US20120059216A1 (en)||2010-09-07||2012-03-08||Allergan, Inc.||Remotely adjustable gastric banding system|
|WO2012045030A3 (en)||2010-10-01||2012-08-16||Intrapace, Inc.||Feedback systems to enhance obstructive and other obesity treatments, optionally using multiple sensors|
|US8961393B2 (en)||2010-11-15||2015-02-24||Apollo Endosurgery, Inc.||Gastric band devices and drive systems|
|WO2012078924A1 (en) *||2010-12-08||2012-06-14||Intrapace, Inc.||Event evaluation using heart rate variation for ingestion monitoring and therapy|
|US8696616B2 (en)||2010-12-29||2014-04-15||Ethicon Endo-Surgery, Inc.||Obesity therapy and heart rate variability|
|WO2012142539A1 (en)||2011-04-14||2012-10-18||Endostim, Inc.||Systems and methods for treating gastroesophageal reflux disease|
|US20130046153A1 (en)||2011-08-16||2013-02-21||Elwha LLC, a limited liability company of the State of Delaware||Systematic distillation of status data relating to regimen compliance|
|US9037245B2 (en)||2011-09-02||2015-05-19||Endostim, Inc.||Endoscopic lead implantation method|
|US8876694B2 (en)||2011-12-07||2014-11-04||Apollo Endosurgery, Inc.||Tube connector with a guiding tip|
|US8961394B2 (en)||2011-12-20||2015-02-24||Apollo Endosurgery, Inc.||Self-sealing fluid joint for use with a gastric band|
|WO2013143600A1 (en) *||2012-03-30||2013-10-03||Ethicon Endo-Surgery, Inc.||Devices and methods for the treatment of metabolic disorders.|
|WO2013143599A1 (en) *||2012-03-30||2013-10-03||Ethicon Endo-Surgery, Inc.||Devices and methods for the treatment of metabolic disorders.|
|WO2013143612A1 (en) *||2012-03-30||2013-10-03||Ethicon Endo-Surgery, Inc.||Devices and methods for the treatment of metabolic disorders|
|JP2015521495A (en) *||2012-06-14||2015-07-30||オートノミクス メディカル，インコーポレーテッド||Device for the diagnosis and treatment of overactive bladder, systems, and methods|
|US9623238B2 (en)||2012-08-23||2017-04-18||Endostim, Inc.||Device and implantation system for electrical stimulation of biological systems|
|CN105073186A (en) *||2013-01-31||2015-11-18||迪格玛医疗有限公司||Methods and systems for reducing neural activity in an organ of a subject|
|US9498619B2 (en)||2013-02-26||2016-11-22||Endostim, Inc.||Implantable electrical stimulation leads|
|US9067070B2 (en)||2013-03-12||2015-06-30||Medibotics Llc||Dysgeusia-inducing neurostimulation for modifying consumption of a selected nutrient type|
|US9456916B2 (en)||2013-03-12||2016-10-04||Medibotics Llc||Device for selectively reducing absorption of unhealthy food|
|US9011365B2 (en)||2013-03-12||2015-04-21||Medibotics Llc||Adjustable gastrointestinal bifurcation (AGB) for reduced absorption of unhealthy food|
|US9168000B2 (en)||2013-03-13||2015-10-27||Ethicon Endo-Surgery, Inc.||Meal detection devices and methods|
|US9827425B2 (en)||2013-09-03||2017-11-28||Endostim, Inc.||Methods and systems of electrode polarity switching in electrical stimulation therapy|
|US20160121111A1 (en) *||2014-11-05||2016-05-05||Enterastim, Inc.||Conditional Gastrointestinal Stimulation for Improved Motility|
|US9682234B2 (en)||2014-11-17||2017-06-20||Endostim, Inc.||Implantable electro-medical device programmable for improved operational life|
|CN104921724A (en) *||2015-07-17||2015-09-23||中国医学科学院生物医学工程研究所||Gastric emptying simulator for electrical impedance imaging detection|
Family Cites Families (68)
|Publication number||Priority date||Publication date||Assignee||Title|
|GB8603099D0 (en)||1986-02-07||1986-03-12||Blass K G||Gastrointestinal module|
|US5876445A (en)||1991-10-09||1999-03-02||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|US5662713A (en)||1991-10-09||1997-09-02||Boston Scientific Corporation||Medical stents for body lumens exhibiting peristaltic motion|
|DE69324625D1 (en) *||1992-05-29||1999-06-02||Valerio Cigaina||Device for treating obesity and the motor disorders of the stomach|
|US6009877A (en)||1994-06-24||2000-01-04||Edwards; Stuart D.||Method for treating a sphincter|
|US5716392A (en)||1996-01-05||1998-02-10||Medtronic, Inc.||Minimally invasive medical electrical lead|
|US6243607B1 (en) *||1996-09-05||2001-06-05||University Technologies International Inc.||Gastro-intestinal electrical pacemaker|
|EP1011804B1 (en)||1997-03-27||2009-08-19||Alfred E. Mann Foundation||System of implantable devices for monitoring and/or affecting body parameters|
|US5861014A (en)||1997-04-30||1999-01-19||Medtronic, Inc.||Method and apparatus for sensing a stimulating gastrointestinal tract on-demand|
|ES2283020T3 (en)||1997-07-16||2007-10-16||Metacure Nv||Smooth muscle controller.|
|US6479523B1 (en)||1997-08-26||2002-11-12||Emory University||Pharmacologic drug combination in vagal-induced asystole|
|US20060116736A1 (en)||2001-07-23||2006-06-01||Dilorenzo Daniel J||Method, apparatus, and surgical technique for autonomic neuromodulation for the treatment of obesity|
|US6205359B1 (en)||1998-10-26||2001-03-20||Birinder Bob Boveja||Apparatus and method for adjunct (add-on) therapy of partial complex epilepsy, generalized epilepsy and involuntary movement disorders utilizing an external stimulator|
|US6366814B1 (en)||1998-10-26||2002-04-02||Birinder R. Boveja||External stimulator for adjunct (add-on) treatment for neurological, neuropsychiatric, and urological disorders|
|WO2000030534A1 (en)||1998-11-25||2000-06-02||Ball Semiconductor, Inc.||Spherically-shaped biomedical ic|
|US6427089B1 (en)||1999-02-19||2002-07-30||Edward W. Knowlton||Stomach treatment apparatus and method|
|WO2000059376A1 (en)||1999-04-07||2000-10-12||Endonetics, Inc.||Implantable monitoring probe|
|US6285897B1 (en)||1999-04-07||2001-09-04||Endonetics, Inc.||Remote physiological monitoring system|
|US6684104B2 (en)||1999-04-14||2004-01-27||Transneuronix, Inc.||Gastric stimulator apparatus and method for installing|
|US6895278B1 (en)||1999-04-14||2005-05-17||Transneuronix, Inc.||Gastric stimulator apparatus and method for use|
|EP1180004A1 (en) *||1999-05-18||2002-02-20||Silhouette Medical Inc.||Surgical weight control device|
|US6606518B1 (en)||1999-08-06||2003-08-12||Transneuronix, Inc.||Apparatus and process for stimulation of a state of complete continence in the neospincter in the preparation of continent neostomies|
|US6551304B1 (en) *||1999-12-01||2003-04-22||Abbeymoor Medical, Inc.||Magnetic retrieval device and method of use|
|US6454785B2 (en)||2000-02-24||2002-09-24||DE HOYOS GARZA ANDRéS||Percutaneous intragastric balloon catheter for the treatment of obesity|
|US6826428B1 (en)||2000-04-11||2004-11-30||The Board Of Regents Of The University Of Texas System||Gastrointestinal electrical stimulation|
|EP1272250A4 (en)||2000-04-11||2003-07-09||Univ Texas||Gastrointestinal electrical stimulation|
|ES2381092T3 (en) *||2000-07-19||2012-05-23||Critical Perfusion, Inc||Catheter for use in a system for monitoring mucosal damage in hollow viscous organs|
|WO2002032499A9 (en)||2000-09-15||2003-07-31||Alfred E Mann Inst Biomed Eng||Method and apparatus to treat disorders of gastrointestinal peristalsis|
|US20020072780A1 (en)||2000-09-26||2002-06-13||Transneuronix, Inc.||Method and apparatus for intentional impairment of gastric motility and /or efficiency by triggered electrical stimulation of the gastrointestinal tract with respect to the intrinsic gastric electrical activity|
|WO2002026101A3 (en)||2000-09-29||2002-08-22||Pnina Abramovitz-Shnaider||System and method for the control of behavioral disorders|
|US6591137B1 (en) *||2000-11-09||2003-07-08||Neuropace, Inc.||Implantable neuromuscular stimulator for the treatment of gastrointestinal disorders|
|US6600953B2 (en)||2000-12-11||2003-07-29||Impulse Dynamics N.V.||Acute and chronic electrical signal therapy for obesity|
|CN100366310C (en)||2001-01-05||2008-02-06||超治疗股份有限公司||Regulation of eating habits|
|US6754536B2 (en) *||2001-01-31||2004-06-22||Medtronic, Inc||Implantable medical device affixed internally within the gastrointestinal tract|
|US6775573B2 (en)||2001-03-01||2004-08-10||Science Medicus Inc.||Electrical method to control autonomic nerve stimulation of gastrointestinal tract|
|JP4246998B2 (en)||2001-04-18||2009-04-02||インパルス ダイナミックス エヌヴィ||Analysis of eating habits|
|US6535764B2 (en) *||2001-05-01||2003-03-18||Intrapace, Inc.||Gastric treatment and diagnosis device and method|
|US6928320B2 (en)||2001-05-17||2005-08-09||Medtronic, Inc.||Apparatus for blocking activation of tissue or conduction of action potentials while other tissue is being therapeutically activated|
|US6558400B2 (en) *||2001-05-30||2003-05-06||Satiety, Inc.||Obesity treatment tools and methods|
|US7209783B2 (en) *||2001-06-15||2007-04-24||Cardiac Pacemakers, Inc.||Ablation stent for treating atrial fibrillation|
|US7054692B1 (en)||2001-06-22||2006-05-30||Advanced Bionics Corporation||Fixation device for implantable microdevices|
|US7160258B2 (en) *||2001-06-26||2007-01-09||Entrack, Inc.||Capsule and method for treating or diagnosing the intestinal tract|
|US6901295B2 (en) *||2001-07-14||2005-05-31||Virender K. Sharma||Method and apparatus for electrical stimulation of the lower esophageal sphincter|
|US7599736B2 (en) *||2001-07-23||2009-10-06||Dilorenzo Biomedical, Llc||Method and apparatus for neuromodulation and physiologic modulation for the treatment of metabolic and neuropsychiatric disease|
|US7338444B2 (en)||2002-06-28||2008-03-04||Oridion Breathid Ltd||Management of gastro-intestinal disorders|
|US6675809B2 (en)||2001-08-27||2004-01-13||Richard S. Stack||Satiation devices and methods|
|US20030125788A1 (en) *||2001-11-09||2003-07-03||Long Gary L.||Self-propelled, intraluminal device with electrode configuration and method of use|
|US20030120328A1 (en)||2001-12-21||2003-06-26||Transneuronix, Inc.||Medical implant device for electrostimulation using discrete micro-electrodes|
|US20030144708A1 (en)||2002-01-29||2003-07-31||Starkebaum Warren L.||Methods and apparatus for retarding stomach emptying for treatment of eating disorders|
|JP4351458B2 (en)||2002-03-18||2009-10-28||アンソニー・ニコラス・カルー||The endoscope insertion system|
|US7689276B2 (en)||2002-09-13||2010-03-30||Leptos Biomedical, Inc.||Dynamic nerve stimulation for treatment of disorders|
|US7463934B2 (en)||2002-04-12||2008-12-09||Medtronic, Inc.||Implantable medical device with captivation fixation|
|US20040015201A1 (en)||2002-04-22||2004-01-22||Transneuronix, Inc.||Process for electrostimulation treatment of obesity|
|US7020526B1 (en)||2002-05-16||2006-03-28||Ruan Jin Zhao||Electronic gastro-intestinal stimulation device|
|JP2005533613A (en)||2002-07-26||2005-11-10||トランスニューロニックス インコーポレイテッド||Improved method for electrical stimulation treatment of morbid obesity|
|US20040093039A1 (en)||2002-10-25||2004-05-13||Raphael Schumert||Gastrointestinal pacemaker|
|US7025791B2 (en)||2002-12-02||2006-04-11||Gi Dynamics, Inc.||Bariatric sleeve|
|JP2004201901A (en) *||2002-12-25||2004-07-22||Yoshimi Kurokawa||Stomach electrostimulator|
|US20040172084A1 (en)||2003-02-03||2004-09-02||Knudson Mark B.||Method and apparatus for treatment of gastro-esophageal reflux disease (GERD)|
|US7444183B2 (en) *||2003-02-03||2008-10-28||Enteromedics, Inc.||Intraluminal electrode apparatus and method|
|US7620454B2 (en)||2003-05-19||2009-11-17||Medtronic, Inc.||Gastro-electric stimulation for reducing the acidity of gastric secretions or reducing the amounts thereof|
|US7742818B2 (en)||2003-05-19||2010-06-22||Medtronic, Inc.||Gastro-electric stimulation for increasing the acidity of gastric secretions or increasing the amounts thereof|
|US7082336B2 (en) *||2003-06-04||2006-07-25||Synecor, Llc||Implantable intravascular device for defibrillation and/or pacing|
|US9498366B2 (en)||2003-07-28||2016-11-22||Baronova, Inc.||Devices and methods for pyloric anchoring|
|US7263405B2 (en)||2003-08-27||2007-08-28||Neuro And Cardiac Technologies Llc||System and method for providing electrical pulses to the vagus nerve(s) to provide therapy for obesity, eating disorders, neurological and neuropsychiatric disorders with a stimulator, comprising bi-directional communication and network capabilities|
|US7054690B2 (en) *||2003-10-22||2006-05-30||Intrapace, Inc.||Gastrointestinal stimulation device|
|US20050222637A1 (en)||2004-03-30||2005-10-06||Transneuronix, Inc.||Tachygastrial electrical stimulation|
|US20050222638A1 (en)||2004-03-30||2005-10-06||Steve Foley||Sensor based gastrointestinal electrical stimulation for the treatment of obesity or motility disorders|
Also Published As
|Publication number||Publication date||Type|
|Peckham et al.||Functional electrical stimulation for neuromuscular applications|
|US7292890B2 (en)||Vagus nerve stimulation via unidirectional propagation of action potentials|
|US7115095B2 (en)||Systems and methods for detecting, diagnosing and treating congestive heart failure|
|US6853862B1 (en)||Gastroelectric stimulation for influencing pancreatic secretions|
|US6449512B1 (en)||Apparatus and method for treatment of urological disorders using programmerless implantable pulse generator system|
|US7899539B2 (en)||Cavernous nerve stimulation via unidirectional propagation of action potentials|
|US7558629B2 (en)||Energy balance therapy for obesity management|
|US4543955A (en)||System for controlling body implantable action device|
|US7616990B2 (en)||Implantable and rechargeable neural stimulator|
|US7167751B1 (en)||Method of using a fully implantable miniature neurostimulator for vagus nerve stimulation|
|US20060190048A1 (en)||Implantable neurostimulator supporting trial and chronic modes|
|US20050143784A1 (en)||Gastrointestinal anchor with optimal surface area|
|US7899541B2 (en)||Systems and methods for implantable leadless gastrointestinal tissue stimulation|
|US20050251182A1 (en)||Surgical ring featuring a reversiblediameter remote control system|
|US20040015205A1 (en)||Implantable microstimulators with programmable multielectrode configuration and uses thereof|
|US5480420A (en)||Resorbable temporary medical electrode device|
|US6564101B1 (en)||Electrical system for weight loss and laparoscopic implanation thereof|
|US20070123809A1 (en)||Extending intrabody capsule|
|US20110307027A1 (en)||Device and implantation system for electrical stimulation of biological systems|
|US6432040B1 (en)||Implantable esophageal sphincter apparatus for gastroesophageal reflux disease and method|
|US20060247718A1 (en)||Dual mode electrical stimulation to treat obesity|
|US20060009815A1 (en)||Method and system to provide therapy or alleviate symptoms of involuntary movement disorders by providing complex and/or rectangular electrical pulses to vagus nerve(s)|
|US20090240100A1 (en)||Method for controlling flow of intestinal contents in a patient's intestines|
|US7729772B2 (en)||Implantable neuromodulation system and method|
|US20030018365A1 (en)||Method and apparatus for the treatment of urinary tract dysfunction|
Effective date: 20131009